Skip to main content
All lobbying filings

W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q2 report for GLAXOSMITHKLINE on July 20, 2026, reporting $40,000 in lobbying income.

Lobbying for GLAXOSMITHKLINE · Healthcare company.

All filings by W STRATEGIES, LLC · Everything GLAXOSMITHKLINE has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Implementation of H.R.5376 - Inflation Reduction Act of 2022. Issues around access to vaccines Public Law 119-21: One Big Beautiful Bill Act. Issues around drug pricing.

 Bills named in this filing 1
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem